| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/16/2014 | CN102579453B 一种治疗胃溃疡的复方制剂及其制备方法 A gastric ulcer compound and its preparation method of treatment |
| 07/16/2014 | CN102573722B 制造贴剂的方法及装置 Method and apparatus for manufacturing a patch |
| 07/16/2014 | CN102552165B 一种盐酸沙格雷酯缓释微丸及其制备方法 One kind Sarpogrelate hydrochloride sustained-release pellets and its preparation method |
| 07/16/2014 | CN102552164B 一种枸橼酸钾缓释微丸及其制备方法 One kind of sustained-release pellets of potassium citrate and its preparation method |
| 07/16/2014 | CN102526142B 乌骨藤颗粒冲剂及其制备方法 Black bone vine granule and its preparation method |
| 07/16/2014 | CN102525990B 一种艾普拉唑肠溶片剂及其制备方法 One kind ilaprazole enteric tablet and its preparation method |
| 07/16/2014 | CN102525943B 一种微丸及其制备方法 One kind of pellets and its preparation method |
| 07/16/2014 | CN102379936B 一种解酒护肝软胶囊的生产工艺 One kind of hangover Liver soft capsule production process |
| 07/16/2014 | CN102368999B 抗坏血酸磷酸酯缓释体系 Ascorbic acid phosphate delivery system |
| 07/16/2014 | CN102357080B 一种酸性环境中可实现药物快速释放的智能型多功能空心微球及其制备方法 An acidic environment can be achieved Intelligent Multifunctional hollow microspheres and drug preparation quick release |
| 07/16/2014 | CN102349939B 雪莲提取物微乳剂组合物 Lotus extract microemulsion composition |
| 07/16/2014 | CN102319181B 一种微囊型动物药品的包被工艺 One kind of animal drug microcapsule type packets are process |
| 07/16/2014 | CN102300561B 包含依泽替米贝和辛伐他汀的药物组合物 Contains ezetimibe and simvastatin pharmaceutical composition |
| 07/16/2014 | CN102231980B 包含氧清除剂的苏芬太尼(sufentanil)固体剂型和其使用方法 Sufentanil (sufentanil) solid dosage form containing an oxygen scavenger and their use |
| 07/16/2014 | CN102215847B 碳酸钙片剂的改善的溶出稳定性 Dissolution of calcium carbonate tablets with improved stability |
| 07/16/2014 | CN101932311B 微粒及其药物组合物 Particles and pharmaceutical compositions thereof |
| 07/16/2014 | CN101674810B 针对癌细胞和癌相关成纤维细胞的靶向剂 For cancer cells and cancer-associated fibroblasts targeting agent |
| 07/16/2014 | CN101455650B 经皮吸收贴剂及制造方法 Transdermal absorption patch and method of manufacture |
| 07/16/2014 | CN101123996B 用于增强成像对比度的组合物和方法 Contrast enhanced imaging compositions and methods for |
| 07/15/2014 | US8779114 siRNA conjugate and preparation method thereof |
| 07/15/2014 | US8779107 Composition for targeting dendritic cells |
| 07/15/2014 | US8779089 Methods and compositions for soft tissue repair |
| 07/15/2014 | US8779008 Polymeric micelles for drug delivery |
| 07/15/2014 | US8779007 Preparation containing diol |
| 07/15/2014 | US8779004 Stable emulsion formulations |
| 07/15/2014 | US8779000 Saccharide free, storage stable thyroid hormone active drug formulations and methods for their production |
| 07/15/2014 | US8778999 Non-steroidal anti-inflammatory ophthalmic compositions |
| 07/15/2014 | US8778981 Methods and compositions for locally increasing body fat |
| 07/15/2014 | US8778922 Steroidal compositions |
| 07/15/2014 | US8778921 Ansamycin hydroquinone compositions |
| 07/15/2014 | US8778917 Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same |
| 07/15/2014 | US8778913 Antimicrobial compositions for treating microbial infections |
| 07/15/2014 | US8778909 Method of applying an injectable filler |
| 07/15/2014 | US8778908 Cystitis treatment with high dose chondroitin sulfate |
| 07/15/2014 | US8778902 RNA interference mediating small RNA molecules |
| 07/15/2014 | US8778889 Antimicrobial decapeptide oral hygiene treatment |
| 07/15/2014 | US8778883 Foamy biomaterial for biological tissue repair |
| 07/15/2014 | US8778876 Small-molecule inhibitors of Dengue and West Nile virus proteases |
| 07/15/2014 | US8778869 Tissue regeneration system |
| 07/15/2014 | US8778868 Chemically defined vaccine stabiliser |
| 07/15/2014 | US8778422 Compositions for treating degenerative joint diseases |
| 07/15/2014 | US8778413 Dosing regimens and methods of treatment using carbon monoxide |
| 07/15/2014 | US8778406 Anti-chafing aerosol powder |
| 07/15/2014 | US8778403 Diketopiperazine microparticles with defined specific surface areas |
| 07/15/2014 | US8778402 Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation |
| 07/15/2014 | US8778401 Mesoporous material excipients for poorly aqueous soluble ingredients |
| 07/15/2014 | US8778400 Nanoparticle-stabilized capsule formulation for treatment of inflammation |
| 07/15/2014 | US8778399 In situ, liquid-activated film coated tablets and a process for making the same |
| 07/15/2014 | US8778398 Immediate release formulations and dosage forms of gamma-hydroxybutyrate |
| 07/15/2014 | US8778397 Stabilized tolterodine tartrate formulations |
| 07/15/2014 | US8778396 Multi-unit gastroretentive pharmaceutical dosage form comprising microparticles |
| 07/15/2014 | US8778395 Diltiazem controlled release formulation and method of manufacture |
| 07/15/2014 | US8778394 Small-volume oral transmucosal dosage forms |
| 07/15/2014 | US8778393 Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
| 07/15/2014 | US8778392 Oral disintegrating tablet |
| 07/15/2014 | US8778391 Flurbiprofen and muscle relaxant combinations |
| 07/15/2014 | US8778390 Orally effective methylphenidate extended release powder and aqueous suspension product |
| 07/15/2014 | US8778389 Medicament for the treatment of fungal infections particularly aspergillosis |
| 07/15/2014 | US8778388 Acidic carrageenan composition for external use |
| 07/15/2014 | US8778383 Methods of treatment |
| 07/15/2014 | US8778382 Tamper resistant transdermal dosage form |
| 07/15/2014 | US8778381 Ocular implant made by a double extrusion process |
| 07/15/2014 | US8778380 Apparatus for fabricating 3D scaffold for inserting in a body to regenerate tissue |
| 07/15/2014 | US8778378 Bioactive antibacterial bone graft materials |
| 07/15/2014 | US8778376 Copolymer comprising elastin pentapeptide block and hydrophilic block, and medical device and method of treating |
| 07/15/2014 | US8778368 Use of acrylic comb copolymers as a colour developing agent in cosmetic compositions |
| 07/15/2014 | US8778367 Glycerosomes and use thereof in pharmaceutical and cosmetic preparations for topical applications |
| 07/15/2014 | US8778365 Topical compositions and methods for making and using same |
| 07/15/2014 | US8778364 Nanodispersion of a drug and process for its preparation |
| 07/15/2014 | US8778362 Anti-tumor/cancer heterologous acellular collagenous preparations and uses thereof |
| 07/15/2014 | US8778360 Extracellular matrix cancer vaccine adjuvant |
| 07/15/2014 | US8778333 Injectable microspheres for tissue construction |
| 07/15/2014 | US8778324 Ion binding polymers and uses thereof |
| 07/15/2014 | US8778322 pH responsive biodegradable polylactic acid derivatives forming polymeric micelles and uses thereof for poorly water soluble drug delivery |
| 07/15/2014 | US8778314 Co-polymers in hair styling applications |
| 07/15/2014 | US8778306 Colon lavage system |
| 07/15/2014 | US8777134 Suspension comprising benzimidazole carbamate and a polysorbate |
| 07/15/2014 | US8776802 Methods and systems for prolonged localization of drug delivery |
| 07/15/2014 | CA2792232C A device for the manufacture of a dosage form with a hole and method of manufacture |
| 07/15/2014 | CA2752550C Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione |
| 07/15/2014 | CA2746983C Preparation method of polymeric micelles composition containing a poorly water-soluble drug |
| 07/15/2014 | CA2659322C Compositions containing quaternary ammonium compounds |
| 07/15/2014 | CA2651450C Anti-cancer medication intended for immunotherapy treatments |
| 07/15/2014 | CA2650833C Autodestructive transdermal therapeutic system |
| 07/15/2014 | CA2602184C Tablet |
| 07/15/2014 | CA2585721C Non-gelatin soft capsule system |
| 07/15/2014 | CA2564961C Pharmaceutical tablets having a relatively inactive segment |
| 07/15/2014 | CA2548305C Use of alginate matrices to control cell growth |
| 07/15/2014 | CA2483913C Vascularization enhanced graft constructs comprising basement membrane |
| 07/10/2014 | WO2014107731A1 Therapeutic vaccines for treating herpes simplex virus type 2 infections |
| 07/10/2014 | WO2014107617A1 Delayed-release composition comprising biguanide |
| 07/10/2014 | WO2014107571A1 Methods for isolating microvesicles |
| 07/10/2014 | WO2014107566A1 Surface binding of nanoparticle based drug delivery to tissue |
| 07/10/2014 | WO2014107419A1 Use of oscillating gradients of high magnetic field for specific destruction of cells labeled with magnetic nanoparticles |
| 07/10/2014 | WO2014107055A1 Mri contrast agent including t1 contrast material coated on surface of nanoparticle support |
| 07/10/2014 | WO2014106962A1 Novel fast-dissolving granule formulation having improved solubility |
| 07/10/2014 | WO2014106943A1 Medicinal composition containing docetaxel |
| 07/10/2014 | WO2014106865A1 Abuse-proofed, extended release pharmaceutical composition comprising tapentadol or a pharmaceutically acceptable salt thereof and processes for preparing thereof |
| 07/10/2014 | WO2014106727A1 Inhaler and formulation |
| 07/10/2014 | WO2014106541A1 Dermal composition for use in the external genital area in females |